Full article view2018-07-17T08:45:50+00:00
Back to News & Insights »

Precision for Value's Jackie DeAngelis Discusses Common Launch Mistakes

 

In a new commentary for PharmExec.com, Precision for Value SVP and Managing Director Jackie De Angelis outlines some of the most common mistakes that hinder access when launching a new drug. Included in Jackie’s list are launching with a weak payer value message, failing to make a data-driven economic argument for access, and overlooking the pull-through challenge.

To read her commentary, please click here. 

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.

OK